medeora hepatitis introduction
play

MEDEORA-Hepatitis Introduction Agenda: Introduction Hepatitis - PDF document

MEDEORA-Hepatitis Introduction Agenda: Introduction Hepatitis Challenge Introducing MEDEORA-Hepatitis Goal Cooperation of the Department of Virology of the Analysis University of Cologne Benefit Department of


  1. MEDEORA-Hepatitis

  2. Introduction Agenda: Introduction Hepatitis Challenge • Introducing MEDEORA-Hepatitis Goal • Cooperation of the – Department of Virology of the Analysis University of Cologne Benefit – Department of Gastroenterology and Features Infectious Diseases of the University Design of Düsseldorf Timeframe – MEDEORA GmbH Summary

  3. Hepatitis B und C Agenda: Introduction Hepatitis Challenge Goal Analysis Benefit Features Design Timeframe Summary Aus dem Epidemiologischen Bulletin Nr. 46 vom 18.11.2005 Herausg. RKI Berlin

  4. Challenge Agenda: Introduction Hepatitis Challenge • New therapeutic options lead to an Goal increasing demand of structured clinical Analysis data and observational studies Benefit • New diagnostic possibilities allow a new focus on the disease Features • Long term follow up and epidemiologic Design data of large cohorts are missing Timeframe Summary

  5. Goal Agenda: Introduction • Developement of a new Software to store and proceed clinical data of Hepatitis hepatitis infected patients Challenge • Integration of interfaces to medical Goal information management systems Analysis • Adoption of well proved concepts of Benefit MEDEORA-HIV Features • First steps with a small, modular solution for the collection of clinical- and Design resistance data Timeframe • Additional modules (e.g. interfaces, Summary reports, quality assurance) can be added if necessary

  6. Features Agenda: Introduction Hepatitis • Complete manual data entry • Data validation and consistency checks Challenge • Interfaces for hospital Information Goal Systems and virologic data Analysis • Doctor` s letter Benefit • Patient synopsis Features • BfArM-Form Design • Improved graphical analysis Timeframe • Lab Sample administration (optional) Summary

  7. Design Agenda: Introduction Hepatitis Challenge Goal Analysis Benefit Features Design Timeframe Summary

  8. Benefit Agenda: Introduction Hepatitis Challenge • Low threshold for data entry due to Goal various interfaces • The software allows a broad range of Analysis possibilities regarding epidemiological Benefit and clinical questions Features • Standard data set offers easy analysis Design similar to a centralised cohort – without data protection and data security issues Timeframe Summary

  9. Analysis Agenda: Physicians Manual HIS Other Software Entry Interfaces Introduction Hepatitis Laboratory System Aggregation Challenge Goal Analysis Benefit Central Features MEDEORA-Hepatitis Analysis Design Timeframe Aggregation Summary Laboratory System Physicians Manual HIS Other Software Entry Interfaces

  10. Summary Timeframe Design Features Benefit Analysis Goal Challenge Hepatitis Introduction Agenda: May Project‘s timeframe Jun End of Design Phase Jul Launch of ß-Version Aug QA and Bug Fixing Sep Completion of Final Version Setup Download Area Final Bug Fixing Oct Official Launch of Final Version Nov

  11. Summary Agenda: Introduction • A new software for the documentation of Hepatitis clinical data of Hepatitis infected patients Challenge will be completed at the end of 2008 Goal • Various interfaces reduce manual data entry to a minimum Analysis • The project is starting in a small setting Benefit with a few centers but can be expanded Features easily to other participants Design • A freeware version (like MEDEORA-HIV) of MEDEORA-Hepatitis is planned Timeframe • The website www.medeora.com updates Summary on the project‘s progress

  12. Thank you for your attention

  13. MEDEORA Business Volume Agenda: Introduction Hepatitis Challenge Goal Analysis Benefit Features Design Timeframe Summary

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend